# Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

> **NCT03196661** · PHASE1 · COMPLETED · sponsor: **Hualan Biological Bacterin Co. Ltd.** · enrollment: 588 (actual)

## Conditions studied

- Influenza A

## Interventions

- **BIOLOGICAL:** Influenza A (H7N9) virus vaccine

## Key facts

- **NCT ID:** NCT03196661
- **Lead sponsor:** Hualan Biological Bacterin Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-06
- **Primary completion:** 2016-07-05
- **Final completion:** 2017-03-23
- **Target enrollment:** 588 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03196661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03196661, "Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03196661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*